Why pharma manufacturers are still investing in Europe

Nonetheless, manufacturing projects continue to emerge. In October 2025, CDMO AGC Pharma Chemicals, a European subsidiary of the Japanese AGC Group, inaugurated a new facility to produce highly potent APIs in Barcelona, Spain. AGC acquired the plant from Boehringer Ingelheim in 2019 and invested over €100m ($119m) to increase productive capacity, seeking to use the plant to serve European and US customers, according to Takuma Yamamoto, director of strategic planning and global marketing at AGC Pharma.In Apr ...